Literature DB >> 11110066

Influence of psychiatric comorbidity on HIV risk behaviors: changes during drug abuse treatment.

V L King1, M S Kidorf, K B Stoller, R K Brooner.   

Abstract

This study evaluated whether psychiatric comorbidity is related to change in HIV high risk behaviors during outpatient drug abuse treatment. Participants were opioid abusers entering methadone treatment. Psychiatric and substance use diagnoses were determined at intake. Information on HIV high risk drug use and sexual behaviors, psychosocial functioning, and urine toxicology was assessed at intake and at month six. Subjects were divided into those with versus without a lifetime comorbid non-substance use psychiatric disorder. The comorbid group reported more injection equipment sharing, lower rates of condom use, and higher rates of alcohol use at intake and follow-up. Overall injection drug use behavior decreased over the follow-up period for both groups, however. Methadone treatment had a beneficial effect on HIV risk behaviors, and though some risk behaviors improved signiticantly for both groups, comorbid subjects continued to have higher rates of HIV risk factors than noncomorbid subjects.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11110066     DOI: 10.1300/J069v19n04_07

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  13 in total

1.  Recent sex trade and injection drug use among pregnant opiate and cocaine dependent women in treatment: The significance of psychiatric comorbidity.

Authors:  Courtenay E Cavanaugh; William W Latimer
Journal:  Addict Disord Their Treat       Date:  2010-03

2.  History of sexual trauma and recent HIV-risk behaviors of community-recruited substance using women.

Authors:  Sharon D Johnson; Linda B Cottler; Arbi Ben Abdallah; Catina Callahan O'Leary
Journal:  AIDS Behav       Date:  2011-01

Review 3.  Importance of clinical diagnoses for comorbidity studies in substance use disorders.

Authors:  Marta Torrens; Rocío Martin-Santos; Sharon Samet
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

4.  Quality of life in a community sample of young cocaine and/or heroin users: the role of mental disorders.

Authors:  M Chahua; A Sánchez-Niubò; M Torrens; L Sordo; M J Bravo; M T Brugal; A Domingo-Salvany
Journal:  Qual Life Res       Date:  2015-02-15       Impact factor: 4.147

Review 5.  Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection.

Authors:  Linda R Gowing; Michael Farrell; Reinhard Bornemann; Lynn E Sullivan; Robert L Ali
Journal:  J Gen Intern Med       Date:  2005-12-07       Impact factor: 5.128

6.  Psychiatric severity and HIV-risk sexual behaviors among persons with substance use disorders.

Authors:  John M Majer; Anne C Komer; Leonard A Jason
Journal:  J Dual Diagn       Date:  2015

Review 7.  Reframing "prevention with positives": incorporating counseling techniques that improve the health of HIV-positive patients.

Authors:  Barbara Gerbert; Dale W Danley; Karen Herzig; Kathleen Clanon; Daniel Ciccarone; Paul Gilbert; Michael Allerton
Journal:  AIDS Patient Care STDS       Date:  2006-01       Impact factor: 5.078

8.  Abstinence-contingent reinforcement and engagement in non-drug-related activities among illicit drug abusers.

Authors:  Randall E Rogers; Stephen T Higgins; Kenneth Silverman; Colleen S Thomas; Gary J Badger; George Bigelow; Maxine Stitzer
Journal:  Psychol Addict Behav       Date:  2008-12

9.  Postprison release HIV-risk behaviors in a randomized trial of methadone treatment for prisoners.

Authors:  Monique E Wilson; Timothy W Kinlock; Michael S Gordon; Kevin E O'Grady; Robert P Schwartz
Journal:  Am J Addict       Date:  2012 Sep-Oct

10.  The interaction of active substance use, depression, and antiretroviral adherence in methadone maintenance.

Authors:  Howard Newville; Karina M Berg; Jeffrey S Gonzalez
Journal:  Int J Behav Med       Date:  2015-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.